StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > If we get bought out

<< Previous

Bullboard Posts

Next >>

Comment by Skrit37on Jan 13, 2021 2:34pm

166 Views

Post# 32286626

RE:If we get bought out

Deadornot wrote: I hope it's in a few months after Aristotle's launch and a way higher evaluation. I don't want to get bought out for let's say $2 or $3. I want to get bought out at $10

You may not, but there are many here who would be able to RETIRE..... at 2-3$...

some of us have been here a long time and have gone through tons of these swings

goodluck folks

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity